candesartan has been researched along with Aortic Stenosis in 6 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to evaluate whether treatment with candesartan on top of conventional treatment could prevent new onset AF in patients with aortic valve stenosis (AS) after aortic valve replacement." | 9.17 | Prevention of atrial fibrillation in patients with aortic valve stenosis with candesartan treatment after aortic valve replacement. ( Andersen, LI; Dahl, JS; Haghfelt, T; Møller, JE; Pellikka, PA; Poulsen, MK; Veien, K; Videbæk, L, 2013) |
| " The aim of this study was to evaluate whether treatment with candesartan on top of conventional treatment could prevent new onset AF in patients with aortic valve stenosis (AS) after aortic valve replacement." | 5.17 | Prevention of atrial fibrillation in patients with aortic valve stenosis with candesartan treatment after aortic valve replacement. ( Andersen, LI; Dahl, JS; Haghfelt, T; Møller, JE; Pellikka, PA; Poulsen, MK; Veien, K; Videbæk, L, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Helske-Suihko, S | 1 |
| Laine, M | 1 |
| Lommi, J | 1 |
| Kaartinen, M | 1 |
| Werkkala, K | 1 |
| Kovanen, PT | 1 |
| Kupari, M | 1 |
| Dahl, JS | 3 |
| Videbaek, L | 1 |
| Poulsen, MK | 3 |
| Pellikka, PA | 3 |
| Veien, K | 2 |
| Andersen, LI | 2 |
| Haghfelt, T | 2 |
| Møller, JE | 3 |
| Benedetto, U | 1 |
| Melina, G | 1 |
| Refice, S | 1 |
| di Bartolomeo, R | 1 |
| Roscitano, A | 1 |
| Angeloni, E | 1 |
| Sinatra, R | 1 |
| Pocock, SJ | 1 |
| Ariti, CA | 1 |
| Collier, TJ | 1 |
| Wang, D | 1 |
| Videbæk, L | 2 |
| Rudbæk, TR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Potential of Candesartan to Retard the Progression of Aortic Stenosis Influences of Medical Therapy to the Atheroinflammatory Process in Stenotic Aortic Valves[NCT00699452] | Phase 3 | 120 participants (Anticipated) | Interventional | 2009-05-31 | Recruiting | ||
| Beneficio Del Bloqueo Del Sistema Renina-angiotensina Sobre la evolución clínica y el Remodelado Ventricular Tras la colocación de Una prótesis percutánea aórtica (RASTAVI)[NCT03201185] | Phase 4 | 194 participants (Actual) | Interventional | 2018-02-10 | Active, not recruiting | ||
| Efficacy and Safety of Treatment With Convalescent Plasma for Adults With COVID-19 Pneumonia. A Double-blinded, Randomized, Multicenter Placebo-controlled Trial[NCT04345289] | Phase 3 | 147 participants (Actual) | Interventional | 2020-05-01 | Terminated (stopped due to DSMB advise due to high probability of futility) | ||
| Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis - Effect of Blockade of the Angiotensin-II Receptor[NCT00294775] | Phase 3 | 140 participants (Anticipated) | Interventional | 2006-02-28 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for candesartan and Aortic Stenosis
| Article | Year |
|---|---|
Is blockade of the Renin-Angiotensin system able to reverse the structural and functional remodeling of the left ventricle in severe aortic stenosis?
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Aortic Valve Stenosis; Benzimidazo | 2015 |
Effect of candesartan treatment on left ventricular remodeling after aortic valve replacement for aortic stenosis.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Aortic Valve Stenosis; Benzimidazo | 2010 |
Dual renin-angiotensin system blockade for patients with prosthesis-patient mismatch.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-C | 2010 |
Prevention of atrial fibrillation in patients with aortic valve stenosis with candesartan treatment after aortic valve replacement.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Aortic Valve Stenosis; Atrial Fibr | 2013 |
Global strain in severe aortic valve stenosis: relation to clinical outcome after aortic valve replacement.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Aortic Valve; Aortic Valve Stenosi | 2012 |
1 other study available for candesartan and Aortic Stenosis
| Article | Year |
|---|---|
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities.
Topics: Angiotensin II Type 1 Receptor Blockers; Aortic Valve Stenosis; Benzimidazoles; Biphenyl Compounds; | 2012 |